Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving hundreds of leading biopharmaceutical companies globally:

Accenture
Citi
Fish and Richardson
Cantor Fitzgerald
Express Scripts
McKesson
Harvard Business School
Queensland Health
Argus Health

Generated: April 24, 2018

DrugPatentWatch Database Preview

DOXORUBICIN HYDROCHLORIDE (LIPOSOMAL) Drug Profile

« Back to Dashboard

When do Doxorubicin Hydrochloride (liposomal) patents expire, and when can generic versions of Doxorubicin Hydrochloride (liposomal) launch?

Doxorubicin Hydrochloride (liposomal) is a drug marketed by Dr Reddys Labs Ltd and Sun Pharma Global and is included in two NDAs.

The generic ingredient in DOXORUBICIN HYDROCHLORIDE (LIPOSOMAL) is doxorubicin hydrochloride. There are seventeen drug master file entries for this compound. Sixteen suppliers are listed for this compound. Additional details are available on the doxorubicin hydrochloride profile page.
Drug patent expirations by year for DOXORUBICIN HYDROCHLORIDE (LIPOSOMAL)
Pharmacology for DOXORUBICIN HYDROCHLORIDE (LIPOSOMAL)
Medical Subject Heading (MeSH) Categories for DOXORUBICIN HYDROCHLORIDE (LIPOSOMAL)
Synonyms for DOXORUBICIN HYDROCHLORIDE (LIPOSOMAL)
(7S,9S)-7-(4-amino-5-hydroxy-6-methyl-tetrahydropyran-2-yl)oxy-6,9,11-trihydroxy-9-(2-hydroxyacetyl)-4-methoxy-8,10-dihydro-7H-tetracene-5,12-dione hydrochloride
(7S,9S)-7-(4-amino-5-hydroxy-6-methyloxan-2-yl)oxy-6,9,11-trihydroxy-9-(2-hydroxyacetyl)-4-methoxy-8,10-dihydro-7H-tetracene-5,12-dione hydrochloride
(8S-cis)-10-((3-Amino-2,3,6-trideoxy-alpha-L-lyxo-hexopyranosyl)oxy)-7,8,9,10-tetrahydro-6,8,11-trihydroxy-8-(hydroxyacetyl)-1-methoxynaphthacene-5,12-dione hydrochloride
(8S,10S)-10-((3-Amino-2,3,6-trideoxy-alpha-L-lyxo-hexopyranosyl)oxy)-8-glycoloyl-7,8,9,10-tetrahydro-6,8,11-trihydroxy-1-methoxy-5,12-naphthacenedione hydrochloride
14-Hydroxydaunomycin, HCl
25316-40-9
4'-epi-Adriamycin hydrochloride
4′-Epidoxorubicin, HCl
5, 10-[(3-amino-2,3,6-trideoxy-.alpha.-L-arabino-hexopyranosyl)oxy]-7,8,9,10-tetrahydro-6,8,11-trihydroxy-8-(hydroxyacetyl)-1-methoxy-, hydrochloride
5, 10-[(3-amino-2,3,6-trideoxy-.alpha.-L-arabino-hexopyranosyl)oxy]-7,8,9,10-tetrahydro-6,8,11-trihydroxy-8-(hydroxyacetyl)-1-methoxy-, hydrochloride, (8S-cis)-
5, 10-[(3-amino-2,3,6-trideoxy-.alpha.-L-lyxo-hexopyranosyl)oxy]-7,8,9,10-tetrahydro-6,8,11-trihydroxy-8-(hydroxyacetyl)-1-methoxy-, hydrochloride, (8S-cis)-
5,12-Naphthacenedione, 10-((3-amino-2,3,6-trideoxy-alpha-L-lyxo-hexopyranosyl)oxy)-7,8,9,10-tetrahydro-6,8,11-trihydroxy-8-(hydroxyacetyl)-1-methoxy-, hydrochloride, (8S-cis)-
5,12-Naphthacenedione, 10-((3-amino-2,3,6-trideoxy-alpha-L-lyxo-hexopyranosyl)oxy)-7,8,9,10-tetrahydro-6,8,11-trihydroxy-8-(hydroxylacetyl)-1-methoxy-, hydrochloride (8S-cis)-
56390-09-1
AC1L1OLL
ADM hydrochloride
ADR
Adriamycin PFS (Pharmacia)
Adriblastina RD
Ambotz25316-40-9
AN-024
AN-11144
BG0176
C27H29NO11.HCl
CCG-208148
CCG-208196
CCRIS 740
CHEMBL543353
D4193
DOX HCl
doxorubicin HCl liposome
Doxorubicin hydrochloride [JAN]
Doxorubicin, Hydrochloride
EINECS 246-818-3
Ellence (Pharmacia)
Epirubicin HCl
FI 6804
L-lyxo-Hexopyranoside,2,3,4,6,11-hexahydro-3,5,12-trihydroxy-10-methoxy-6,11-dioxo-1a-naphthacenyl 3-amino-2,3,6-trideoxy-, .alpha.-, hydrochloride
Lipodox
LS-1077
MLS002702107
MolPort-003-983-428
NSC-123127
NSC-256942
NSC123127
NSC256942
Pidorubicin hydrochloride
SCHEMBL317302
TLK199 HCl Liposomes for Injection

US Patents and Regulatory Information for DOXORUBICIN HYDROCHLORIDE (LIPOSOMAL)

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Dr Reddys Labs Ltd DOXORUBICIN HYDROCHLORIDE (LIPOSOMAL) doxorubicin hydrochloride INJECTABLE, LIPOSOMAL;INJECTION 208657-001 May 15, 2017 AB RX No No ➤ Sign Up ➤ Sign Up ➤ Sign Up
Sun Pharma Global DOXORUBICIN HYDROCHLORIDE (LIPOSOMAL) doxorubicin hydrochloride INJECTABLE, LIPOSOMAL;INJECTION 203263-002 Feb 4, 2013 AB RX No Yes ➤ Sign Up ➤ Sign Up ➤ Sign Up
Dr Reddys Labs Ltd DOXORUBICIN HYDROCHLORIDE (LIPOSOMAL) doxorubicin hydrochloride INJECTABLE, LIPOSOMAL;INJECTION 208657-002 May 15, 2017 AB RX No No ➤ Sign Up ➤ Sign Up ➤ Sign Up
Sun Pharma Global DOXORUBICIN HYDROCHLORIDE (LIPOSOMAL) doxorubicin hydrochloride INJECTABLE, LIPOSOMAL;INJECTION 203263-001 Feb 4, 2013 AB RX No Yes ➤ Sign Up ➤ Sign Up ➤ Sign Up
Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration

This preview shows a limited data set. Subscribe for full access, or try a Free Trial

For more information try a trial or see the plans and pricing

Serving hundreds of leading biopharmaceutical companies globally:

McKesson
Dow
Boehringer Ingelheim
Federal Trade Commission
Covington
Merck
Argus Health
Moodys
Queensland Health

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.